M&G PLC Blueprint Medicines Corp Transaction History
M&G PLC
- $27.7 Trillion
- Q3 2024
A detailed history of M&G PLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, M&G PLC holds 97,861 shares of BPMC stock, worth $8.56 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
97,861Holding current value
$8.56 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$584 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$581 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$471 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$347 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$242 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.22B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...